Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

被引:254
作者
Breen, RAM
Smith, CJ
Bettinson, H
Dart, S
Bannister, B
Johnson, MA
Lipman, MCI
机构
[1] UCL Royal Free Hosp, Dept Thorac & HIV Med, London NW3 2QG, England
[2] UCL Royal Free Hosp, Dept Infect Dis, London NW3 2QG, England
[3] UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England
关键词
D O I
10.1136/thx.2003.019224
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: It has been suggested that deterioration of tuberculosis ( TB) during appropriate treatment, termed a paradoxical reaction ( PR), is more common and severe in HIV positive individuals on highly active antiretroviral therapy ( HAART). Method: A study was undertaken to determine the frequency of PR and its associated features in a population of HIV+TB+ patients and a similar sized group of HIV-TB+ individuals. Results: PR occurred in 28% of 50 HIV+TB+ patients and 10% of 50 HIV-TB+ patients. Disseminated TB was present in eight of 13 HIV+TB+ patients and four of five HIV-TB+ patients with PR. In 28 HIV+TB+ patients starting HAART, PR was significantly associated with commencing HAART within 6 weeks of starting antituberculosis treatment ( p = 0.03) and was more common in those with disseminated TB ( p = 0.09). No association was found between development of PR and baseline CD4 count or CD4 response to HAART. Conclusions: PR is common in HIV infected and uninfected individuals with TB. Early introduction of HAART and the presence of disseminated TB appear to be important in co-infected patients.
引用
收藏
页码:704 / 707
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 1890, DTSCH MED WOCHENSCHR, DOI DOI 10.1055/S-0029-1207546
[2]  
Barry S M, 2002, HIV Med, V3, P207, DOI 10.1046/j.1468-1293.2002.00115.x
[3]   Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung:: A characteristic feature of active pulmonary and nonpulmonary tuberculosis [J].
Barry, SM ;
Lipman, MC ;
Bannister, B ;
Johnson, MA ;
Janossy, G .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (02) :243-250
[4]   LYMPH-NODE TUBERCULOSIS - COMPARISON OF VARIOUS METHODS OF TREATMENT [J].
CAMPBELL, IA ;
DYSON, AJ .
TUBERCLE, 1977, 58 (04) :171-179
[5]  
CHLOREMIS CB, 1955, AM REV TUBERC, V72, P527
[6]   Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy [J].
Dean, GL ;
Edwards, SG ;
Ives, NJ ;
Matthews, G ;
Fox, EF ;
Navaratne, L ;
Fisher, M ;
Taylor, GP ;
Miller, R ;
Taylor, CB ;
de Ruiter, A ;
Pozniak, AL .
AIDS, 2002, 16 (01) :75-83
[7]   IMPACT OF HIV ON TUBERCULOSIS IN ZAMBIA - A CROSS-SECTIONAL STUDY [J].
ELLIOTT, AM ;
LUO, N ;
TEMBO, G ;
HALWIINDI, B ;
STEENBERGEN, G ;
MACHIELS, L ;
POBEE, J ;
NUNN, P ;
HAYES, RJ ;
MCADAM, KPWJ .
BRITISH MEDICAL JOURNAL, 1990, 301 (6749) :412-415
[8]   Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease [J].
Li, TS ;
Tubiana, R ;
Katlama, C ;
Calvez, V ;
Ait Mohand, H ;
Autran, B .
LANCET, 1998, 351 (9117) :1682-1686
[9]   Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS [J].
Narita, M ;
Ashkin, D ;
Hollender, ES ;
Pitchenik, AE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (01) :157-161
[10]   Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy [J].
Navas, E ;
Martín-Dávila, P ;
Moreno, L ;
Pintado, V ;
Casado, JL ;
Fortún, J ;
Pérez-Elías, MJ ;
Gomez-Mampaso, E ;
Moreno, S .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (01) :97-99